None listed
Conditions
Brief summary
The main purpose of this study is to examine the feasibility, of a promising intervention (exercise) that never became a standard treatment but with widespread acceptance with the evidence being mainly anecdotal. This study has been designed to optimise the training, content, and delivery of exercises to participants with menstrual pain. The specific objectives for this study are to: 1.To assess recruitment processes and study uptake to inform the feasibility of running a full study 2. To evaluate the retention rate of participants 3. To evaluate the study protocol 4. To determine the feasibility of the proposed outcome measures 5. To estimate the effect size of the intervention The experimental hypothesis is that a treatment program consisting of aerobic training, strengthening and stretching exercises would be effective in reducing the menstrual pain and severity among women with Primary dysmenorrhea
Interventions
Participants will be made to do pelvic stretching, pelvic rocking and abdominal strengthening exercises for 15 minutes followed by aerobic training on treadmill at an intensity of 70-85% of their maximum heart rate for 30 minutes. Maximum heart rate will be calculated by subtracting the participants age from 220. The training protocol will include a 3 week exercise and treadmill training and the training sessions will be administered and supervised by a trained physiotherapist on a one-on-one participant basis. Frequency of intervention will be for 3 days a week for a maximum of 45 minutes each session.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria: (a) Non-pregnant women with general good health in the age group of 18-45 years with primary dysmenorrhea. (b) Women with regular menstrual cycles and having no pelvic abnormality. (c) Primary dysmenorrhea with pain scoring >4 on the visual analog scale (VAS range 0-10). (d) Not on oral contraceptives and having no secondary dysmenorrhea. (e) Women agreeing to refrain from the use of analgesics or other therapies during the course of their participation in the study.
Exclusion criteria
Exclusion criteria: (a) Women with pelvic abnormalities, chronic pelvic pain or with history of endometriosis. (b) Women on hormonal therapy or oral contraceptive pills and having intra uterine devices. (c) Women with menstrual cycle interval exceeding 30 days.